-
Ab175859-1mgGemtuzumab (anti-CD33) is a monoclonal antibody targeting CD33 antigen, which present on leukemic myeloblasts of acute myeloid leukemia (AML). Gemtuzumab (anti-CD33) can be used for synthesis of antibody-drug conjugate (ADC), Gemtuzumab ozogamicin.
-
Ab175859-5mgGemtuzumab (anti-CD33) is a monoclonal antibody targeting CD33 antigen, which present on leukemic myeloblasts of acute myeloid leukemia (AML). Gemtuzumab (anti-CD33) can be used for synthesis of antibody-drug conjugate (ADC), Gemtuzumab ozogamicin.
-
Ab179007-100μlApplicationIF: 1:1000Flow: 1:100-1:2500
-
Ab179007-1mlApplicationIF: 1:1000Flow: 1:100-1:2500
-
Ab156253-100μgApplicationWB: 1:10,000-1:200,000ELISA: 1:20,000-1:400,000IF: 1:1000
-
Ab156253-1mgApplicationWB: 1:10,000-1:200,000ELISA: 1:20,000-1:400,000IF: 1:1000
-
Ab156257-100μgSecondary antibody, Goat Anti-Mouse IgG H&L (Cy5)
-
Ab156257-1mgSecondary antibody, Goat Anti-Mouse IgG H&L (Cy5)
-
Ab156254-100μgApplicationIF: 1:1000Flow: 1:200-1:2000
-
Ab156254-1mgApplicationIF: 1:1000Flow: 1:200-1:2000
-
Ab179006-100μlApplicationIF: 1:1000Flow: 1:100-1:2500
-
Ab179006-1mlApplicationIF: 1:1000Flow: 1:100-1:2500